2Adult neurogenesis:a real hope or a delusion?Ghulam Hussain，Rabia Akram，Haseeb Anwar，Faiqa Sajid，Tehreem Iman，Hyung Soo Han，Chand Raza，Jose-Luis Gonzalez De AguilarReviews6-15
3Type-B monoamine oxidase inhibitors in neurological diseases:clinical applications based on preclinical findingsMarika Alborghetti，Edoardo Bianchini，Lanfranco De Carolis，Silvia Galli，Francesco E.Pontieri，Domiziana RinaldiReviews16-21
4The future of artificial hibernation medicine:protection of nerves and organs after spinal cord injuryCaiyun Liu，Haixin Yu，Zhengchao Li，Shulian Chen，Xiaoyin Li，Xuyi Chen，Bo ChenReviews22-28
5Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?Marta Zagrebelsky，Martin KorteReviews29-34
6Pharmacological interventions targeting the microcirculation following traumatic spinal cord injuryRongrong Wang，Jinzhu BaiReviews35-42
7Metabolic and proteostatic differences in quiescent and active neural stem cellsJiacheng Yu，Gang Chen，Hua Zhu，Yi Zhong，Zhenxing Yang，Zhihong Jian，Xiaoxing XiongReviews43-48
8Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestorationYe Xiong，Asim Mahmood，Michael ChoppReviews49-54
9Pathological and therapeutic effects of extracellular vesicles in neurological and neurodegenerative diseasesPaula Izquierdo-Altarejos，Victoria Moreno-Manzano，Vicente FelipoReviews55-61
10Emergence of taurine as a therapeutic agent for neurological disordersAshok Jangra，Priyanka Gola，Jiten Singh，Pooja Gond，Swarnabha Ghosh，Mahesh Rachamalla，Abhijit Dey，Danish Iqbal，Mehnaz Kamal，Punya Sachdeva，Saurabh Kumar Jha，Shreesh Ojha，Dinesh Kumar，Niraj Kumar Jha，Hitesh Chopra，Shing Cheng TanReviews62-68
11Lactate metabolism in neurodegenerative diseasesChaoguang Yang，Rui-Yuan Pan，Fangxia Guan，Zengqiang YuanReviews69-74
12Pathogenic and therapeutic role of exosomes in neurodegenerative disordersChrista C.Huber，Hongmin WangReviews75-79
13Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease:beyond the role of amyloid betaMadia Lozupone，Francesco PanzaReviews80-83
14Understanding the spectrum of non-motor symptoms in multiple sclerosis:insights from animal modelsPoornima D.E.Weerasinghe-Mudiyanselage，Joong-Sun Kim，Taekyun Shin，Changjong MoonReviews84-91
15The concept of gene therapy for glaucoma:the dream that has not come true yetRobert Sulak，Xiaonan Liu，Adrian SmedowskiReviews92-99
16Biomaterials-based anti-inflammatory treatment strategies for Alzheimer's diseaseJianjian Chu，Weicong Zhang，Yan Liu，Baofeng Gong，Wenbo Ji，Tong Yin，Chao Gao，Danqi Liangwen，Mengqi Hao，Cuimin Chen，Jianhua Zhuang，Jie Gao，You YinReviews100-115
17Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation:a systematic reviewSusana A.Ferreira，Nuno Pinto，Inês Serrenho，Maria Vaz Pato，Graça BaltazarReviews116-123
18SIRT2 as a potential new therapeutic target for Alzheimer's diseaseNoemi Sola-Sevilla，Elena PuertaReviews124-131
19Strategies for translating proteomics discoveries into drug discovery for dementiaAditi Halder，Eleanor DrummondReviews132-139
20Clinical associations of corneal neuromas with ocular surface diseasesCharmaine Jan Li Toh，Chang Liu，Isabelle Xin Yu Lee，Molly Tzu Yu Lin，Louis Tong，Yu-Chi LiuReviews140-147
